Use of monoclonal antibody-IRDye800CW bioconjugates in the resection of breast cancer

BACKGROUND: Complete surgical resection of breast cancer is a powerful determinant of patient outcome, and failure to achieve negative margins results in reoperation in between 30% and 60% of patients. We hypothesize that repurposing Food and Drug Administration approved antibodies as tumor-targetin...

Fuld beskrivelse

Na minha lista:

Bibliografiske detaljer
Udgivet i:	J Surg Res
Main Authors:	Korb, Melissa L., Hartman, Yolanda E., Kovar, Joy, Zinn, Kurt R., Bland, Kirby I., Rosenthal, Eben L.
Format:	Artigo
Sprog:	Inglês
Udgivet:	2013
Fag:	Article
Online adgang:	https://ncbi.nlm.nih.gov/pmc/articles/PMC4354808/ https://ncbi.nlm.nih.gov/pubmed/24360117 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jss.2013.11.1089
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Use of monoclonal antibody-IRDye800CW bioconjugates in the resection of breast cancer

Lignende værker